For more information or confidential assistance
se habla español


Report Indicates Xarelto Clinical Trials Likely Riddled with Misconduct, Fraud

xarelto pill bottle
The U.S. Food and Drug Administration (FDA) is charged with overseeing the safety and efficacy of new prescription medications for eventual approval. This process involves reviewing sites where clinical trials on medications are performed. Occasionally, health officials discover evidence that drug companies and their researchers have deviated from good clinical practice... Read more »

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

New Xarelto Bleeding Lawsuit Filed in California

xarelto pill bottle
Fraudulent concealment, negligence and fraud are just some of the causes of action leveled against Xarelto manufacturers by a California plaintiff who suffered personal injuries after ingesting the drug. The product liability lawsuit is just one of dozens which claim the anticoagulant is defective and inherently dangerous due to its... Read more »

New Fresenius Dialysis Lawsuit Joins MDL 2428

Mason v. Fresenius Medical Care Holdings, Inc. was filed directly into multidistrict litigation (MDL 2428) on December 10, 2014, joining thousands of similar claims that allege Granuflo and Naturalyte dialysis additives are defective and unreasonably dangerous. Plaintiff Robert Mason brought his product liability complaint individually and on behalf of the... Read more »

Benicar Lawsuits May be Centralized Under MDL

As Benicar lawsuits continue to escalate across the nation, plaintiffs have petitioned the Judicial Panel on Multidistrict Litigation (JPML) to consolidate similar actions that allege severe gastrointestinal injuries. In a motion filed on December 18, plaintiff Annette Johnson asked the JPML to transfer all federally-filed cases to the Northern District... Read more »

Study Shows Xarelto Bleeding Risks Equivalent to Warfarin

New research published in the Canadian Journal of Cardiology suggests that Pradaxa and Xarelto bleeding risks may be no different than those of Warfarin (Coumadin). The study – conducted at Southlake Regional Health Centre in Ontario– examined 901 patients who took Warfarin and newer anticoagulants Pradaxa and Xarelto. After looking... Read more »

Late 2016 Trial Dates for Federal Propecia Lawsuits

U.S. District Judge John Gleeson is overseeing a mounting caseload against pharmaceutical titan, Merck – maker of the popular hair loss drug, Propecia. According to court dockets, more than 1,100 product liability complaints alleging serious sexual side effects are pending against Merck in federal and state courts throughout the country.... Read more »

Research Into Safer Alternatives to Statins

Cholesterol-lowering statins are among world’s most widely prescribed drugs, but concerns about Lipitor side effects, including the increased risk for Type 2 diabetes, has fueled a wave of litigation and further research on safer alternatives. As reported by the New York Times, a new study has found another type of... Read more »